Medindia

X

Lilly Partners With TopCoder, to Find Drug Discovery IT Solutions

Wednesday, May 14, 2008 General News J E 4
Advertisement
GLASTONBURY, Conn., May 13 TopCoder(R), Inc., the leaderin online programming competition, skills assessment and competitive softwaredevelopment, today announced a formal partnership with biopharmaceutical firmEli Lilly and Company (NYSE: LLY). Through the relationship, TopCoder willapply the skills of its global community of top ranked software designers anddevelopers to enhance the software and Information Technology backbone atLilly.

"TopCoder's business model of collaborative software development alignswell with our strategy to leverage external partnerships. By engagingTopCoder to help us tackle complex drug discovery IT issues, we're looking toincrease our overall productivity, accelerate the capabilities of Lillyscientists to deliver medicines to market for urgent medical needs, andultimately improve health outcomes for patients around the world." -- EverettLee, Manager, Discovery Research Information Technology, Eli Lilly andCompany.

As an innovative biopharmaceutical firm, Lilly works with a wide networkof strategic partners seeking answers to some of the world's most urgentmedical needs. The company is currently transforming its business, moving froma Fully Integrated Pharmaceutical Company or FIPCo to a Fully IntegratedPharmaceutical Network or FIPNet, striking up strategic partnerships acrossthe globe. Lilly has engaged TopCoder for new software development initiativeswhich will enhance its process for requesting and distributing chemicalsamples around the world to assist biologists in testing compounds that areused in assays, or defined tests, to determine if a compound or group ofcompounds can achieve a desired goal.

"Outsourcing complex drug discovery IT issues to TopCoder allows Lilly tobecome more productive and ultimately speed their medicines to market, therebyimproving outcomes for patients," said Rob Hughes, president and COO ofTopCoder, Inc. "With a more networked enterprise to leverage collaborationsamongst partners, Lilly is able to capitalize on globally shared knowledge andresources."

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growingportfolio of first-in-class and best-in-class pharmaceutical products byapplying the latest research from its own worldwide laboratories and fromcollaborations with eminent scientific organizations. Headquartered inIndianapolis, Ind., Lilly provides answers -- through medicines andinformation -- for some of the world's most urgent medical needs. Additionalinformation about Lilly is available at www.lilly.com.

About TopCoder, Inc.

TopCoder is the world's largest competitive software development communitywith over 140,000 developers representing over 200 countries. TopCoder hoststhe largest and most comprehensive developer ratings and performance metricsavailable. The TopCoder community builds software for a wide-ranging clientbase through a competitive, rigorous, standards based methodology. Thismethodology results in a highly consistent set of software components allowinga software-as-parts approach to application development. TopCoder makes thislarge library of software components built through competition available toall of our clients. Utilizing a world-wide member base and this library,TopCoder seeks to lower the cost of software development while increasing boththe speed at which applications can be developed and the quality of theultimate application. For more information about sponsoring TopCoder events,recruiting TopCoder members and utilizing TopCoder's software services, visithttp://www.topcoder.com .

TopCoder is a registered trademark of TopCoder, Inc. in the United Statesand other countries. All other product and company names herein may betrademarks of their respective owners.Contact: Jim McKeown TopCoder, Inc. 860.633.5540 jmckeown@topcoder.com

SOUR
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Nile Therapeutics to Present at the Rodman & Rensh...
S
Transdel Pharmaceuticals to Present at Rodman & Re...